Related Experiment Video
Updated: Jul 2, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Converse or reverse? Machine-learning modeling for disease progression: A study based on Alzheimer's disease
Yujing Huang1, Hao Zhang2, Buqing Ma2
1Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310024 Zhejiang Province, China; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, Center for Infectious Disease Research, School of Medicine, Westlake University, Hangzhou 310024 Zhejiang Province, China; Westlake University Research Center for Industries of the Future, Westlake University, Hangzhou 310024 Zhejiang Province, China.
Machine learning effectively classifies cognitive decline trajectories. Random Forest models identified key predictors like cognitive function, amyloid biomarkers, and plasma markers for tracking progression from health to dementia.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Biomarker Discovery
Background:
- Understanding the progression from healthy aging to dementia is complex.
- Identifying reliable markers for cognitive decline trajectories is crucial.
Purpose of the Study:
- To evaluate machine learning models for classifying health-to-dementia trajectories.
- To identify key predictive markers across the cognitive continuum.
Main Methods:
- Five machine learning approaches were assessed using the ADNI cohort (ADNI1, ADNIGO, ADNI2, ADNI3).
- Participants with stable, convertible, and reverse progression trajectories were analyzed.
- Feature importance was evaluated for predictive markers.
Main Results:
- Random Forest demonstrated superior performance with 70.8% sensitivity and 96.8% specificity.
- Key predictors included visuospatial/memory deficits, amyloid uptake variations, plasma APOE4, and neurofilament light chain levels.
- These markers effectively classified participant groups across different disease stages.
Conclusions:
- Machine learning holds significant potential for classifying disease trajectories.
- The study identified crucial clinical and neuroimaging biomarkers for predicting cognitive decline.
More Related Videos
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology